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Summary
Background Rosacea is a chronic inflammatory condition that affects the skin of the
face and the eyes. Erythematotelangiectatic rosacea is characterized by flushing,
oedema and telangiectasia. Patients with rosacea demonstrate elevated densities of
Demodex mites in their skin compared with controls. A bacterium (Bacillus oleronius)
isolated from Demodex mites from a patient with papulopustular rosacea has been
demonstrated to produce antigenic proteins that may play a role in papulopustu-
lar and ocular rosacea.
Objectives To establish whether there was a correlation between the reactivity of
sera from patients with erythematotelangiectatic rosacea to Bacillus antigens, and
to characterize the proteins to which these patients showed reactivity.
Methods Serum samples from patients with erythematotelangiectatic rosacea and
controls were examined for reactivity to Bacillus proteins by Western blot analysis.
Proteins to which the sera reacted were excised from gels, trypsin digested, and
putative identities were assigned following liquid chromatography-mass
spectrometry (LC-MS) analysis.
Results Eighty per cent (21 ⁄26) of patients with erythematotelangiectatic rosacea
showed serum reactivity to the 62- and 83-kDa proteins of B. oleronius, compared
with 40% (9 ⁄22) of controls (P = 0Æ004). The 62-kDa protein was characterized
by LC-MS and showed homology to groEL chaperonin, which provokes a strong
immune response in mammals. The 83-kDa protein showed homology to aconi-
tate hydratase, of which expression is increased in bacteria under oxidative stress,
and which is highly immunogenic.
Conclusions The majority of patients with erythematotelangiectatic rosacea show
serum reactivity to two proteins from B. oleronius, suggesting that this bacterium
may play a role in the induction of this condition. The two proteins to which
patient sera reacted were found to be similar to a heat shock protein and an
enzyme involved in regulating the stress response of the bacterium.
Rosacea is a chronic inflammatory condition of the skin of the
face.1 A formal classification of the disease has been developed
and recognizes a number of subtypes including papulopustular
rosacea (PPR) and erythematotelangiectatic, ocular and phyma-
tous rosacea.2 Although frequently encountered by dermatolo-
gists, rosacea is a complex disease and a variety of factors,
including environmental factors (weather, spicy foods, stress
or physical exertion),3 alterations in the innate immune
response, vascular changes in the skin and the presence of
reactive oxygen species within the skin, may contribute to the
induction and persistence of the condition.3–5 Erythemato-
telangiectatic (type 1) rosacea is characterized by persistent
flushing in the central regions of the face, accompanied by
oedema and telangiectasia.2,5,6 Patients may experience sting-
ing and burning sensations and have extremely sensitive skin
that can be rough or scaly. Many patients with erythemato-
telangiectatic rosacea may simultaneously experience
symptoms of PPR and ⁄or ocular rosacea.5
Light therapy (lasers or intense pulsed light devices) can be
effective in the treatment of erythematotelangiectatic rosacea,
and pulsed dye laser (PDL) is often the most effective.7 PDL
causes photothermolysis, thus inducing selective coagulation of
the superficial blood vessels without further damage. This results
in a significant reduction of telangiectasia and erythema, but also
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induces a reduction in the burning sensation and stinging by
lowering the concentration of the mediators released, especially
the neurotransmitter substance P.8 A major concern when using
this therapy for the treatment of erythematotelangiectatic rosacea
is the generation of purpura, a discoloration caused by bleeding
under the skin surface after treatment, and the fact that it has
limited efficacy for vessels larger than 0Æ2 mm in diameter and
located more than 1 mm from the skin surface.7,9
Patients with rosacea demonstrate an increased density of
Demodex mites compared with unaffected controls.10–12 These
mites can be either Demodex folliculorum or Demodex brevis, and
inhabit the pilosebaceous unit where their food source may
be sebum and ⁄or protein. The nature of the lipids in sebum
from patients with PPR is different from that in sebum from
controls, and thus may facilitate the growth and survival of
mites.13 The significance of the elevated Demodex density in
patients with rosacea has been the subject of much specula-
tion. We previously isolated a bacterium (Bacillus oleronius) from
a Demodex mite from a patient with PPR,14 and demonstrated a
strong correlation between patients’ serum reactivity to Bacillus
antigens and PPR14 and ocular rosacea.15 Western blot analysis
revealed reactivity to two antigenic proteins of size 62 and
83 kDa when probed with sera from patients with rosacea.14
It was postulated that these antigens, along with others, are
released from dead Demodex mites and thus lead to an inflam-
matory reaction around the pilosebaceous unit.16 The elevated
density of Demodex mites in the skin of patients with rosacea
may lead to the release of high levels of stimulatory antigens
and toxins, which leak from the pilosebaceous unit and lead
to neutrophil activation and thus stimulate inflammation.
The aim of the work presented here was to examine the re-
activity of sera from patients with erythematotelangiectatic
rosacea to proteins from B. oleronius in order to establish
whether there was a similar correlation to that seen between
serum reactivity with PPR14 and ocular rosacea.15 The demon-
stration of a role for these bacterial proteins in the erythema
and inflammation associated with erythematotelangiectatic ros-
acea may facilitate the development of more effective and tar-
geted therapies.
Materials and methods
Extraction of bacterial antigens
Nutrient broth (250 mL, pH 7) was inoculated with B. oleronius
and incubated for 48 h at 30 C and 200 r.p.m. Late station-
ary phase cells were sedimented by centrifugation at 4000 g
for 20 min. The supernatant was discarded and cells were
washed twice with PBS (pH 7Æ2). Cells were resuspended in
lysis buffer containing 0Æ2% Triton-X 100 with added protease
inhibitors (10 lg mL)1 each of leupeptin, pepstatin A, aproti-
nin and TLCK). The suspension was inverted for 1 h at 4 C
before sonication at 20% power for three 10 s blasts using a
soniprobe sonicator (Sonopuls HD 2200; Bandelin, Berlin,
Germany). The supernatant was centrifuged at 6000 g at 4 C
for 2 min to separate the protein preparation. Protein concen-
tration was assessed by Bradford assay and the protein was
resuspended (1 lg lL)1) in denaturing sample buffer.
Patient population
Twenty-six patients (nine men, 17 women), Fitzpatrick skin
types II–III, were enrolled in the hospital-based study and the
average age was 48Æ3 years (range 20–83 years). At the time
of serum sampling all enrolled patients were considered to
have subtype 1 rosacea, following dermatological examination.
The criteria used for subtype 1 rosacea assessment were the
presence of persistent redness and ⁄or telangiectatic vessels on
the face (especially in malar regions) without the presence of
papular or pustular lesions. Patients were not receiving antibi-
otic therapy for their condition but were scheduled for laser
therapy. Controls were selected from patients attending hospi-
tal who did not show symptoms of rosacea, on the same day
that serum samples were taken from the patients with rosacea.
A total of 21 controls were enrolled (nine men, 12 women)
and the average age was 54Æ3 years (range 28–80 years). All
patients and controls were informed about the nature of the
study and were enrolled once they agreed to participate. Ethi-
cal permission was granted for this study by Centro Hospitalar
de Vila Nova Gaia ⁄Espinho, Portugal.
Western blot analysis using patient sera
Western blots utilized 12Æ5% (w ⁄v) sodium dodecylsulphate
polyacrylamide gel electrophoresis performed in a discontinu-
ous buffer system, in which each well contained 15 lg of B. ol-
eronius protein extract. Following electrophoresis the protein was
transferred to a nitrocellulose membrane, which was cut into
strips for the testing of individual patient sera. A 5 mL sample
of peripheral blood was drawn from each patient and the serum
was separated from the blood before being stored at )80 C.
Each serum sample was diluted 1 ⁄100 (v ⁄v) with the antibody-
diluting buffer (50 mmol L)1 Tris–HCl, 150 mmol L)1 NaCl)
containing 0Æ05% (v ⁄v) Tween-20, 1% (w ⁄v) bovine serum
albumin (BSA), and 3% (w ⁄v) nonfat dried milk, and used as
the primary antibody. The secondary antibody was antihuman
IgG-horseradish peroxidase-linked whole antibody (Sigma
Aldrich Chemical Co. Ltd, Poole, U.K.), which was diluted
1 ⁄1000 with the antibody-diluting buffer. The immunoreactive
protein bands were visualized by incubating the membranes for
10 min in 10 mg of diaminobenzidine tetrahydrochloride in
15 mL of 100 mmol L)1 Tris–HCl (pH 7) containing 15 lL
of hydrogen peroxide before washing in distilled water and
drying. Western blot analysis was performed without prior
knowledge of the rosacea status of the patient or control.
Liquid chromatography-mass spectrometry analysis of
bacterial proteins
Gel pieces corresponding to protein bands to which sera
reacted were excised and trypsin digested as described
previously.17 Following peptide extraction, identification was
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performed using an Agilent 6340 Ion Trap liquid chromato-
graphy - mass spectrometry (LC-MS) (Agilent Technologies,
Wokingham, U.K.) calibrated using BSA. The resulting mass
lists were BLAST searched using the MASCOT MS ⁄MS ion
search program (Matrix Science, Boston, MA, U.S.A.) available
at http://www.matrixscience.com. Annotated function and
protein information was ascertained through the UNIPROT
database (http://www.uniprot.org). A Z score greater than 68
is considered significant at P < 0Æ05.
LC-MS analysis was employed previously to characterize the
range of proteins released by B. oleronius that may provoke an
immune reaction.16 It was demonstrated that a number of
immunogenic proteins (e.g. peptidoglycan synthesis protein,
flagellin, alkyl hydroperoxide reductase and catalase) were
released from Bacillus cells and could play a role in triggering
an immune reaction (e.g. neutrophil migration, cytokine pro-
duction, degranulation) in and around the pilosebaceous unit,
in vivo.16
Statistics
A X2 test was used to establish the significant difference
between the reactivity of the patient and control sera to Bacillus
proteins.
Results
Response of serum from patients with rosacea to
Bacillus antigens
Serum from patients with rosacea, and age- and sex-matched
controls, was isolated and used to probe membranes contain-
ing Bacillus proteins. Western blots were developed and the re-
activity of each serum sample to the 62- and 83-kDa Bacillus
proteins was examined. The results revealed that 80% (21 ⁄26)
of patients with rosacea showed serum reactivity to the Bacillus
proteins, while serum from 40% (9 ⁄22) of control patients
showed reactivity (P = 0Æ004, Fig. 1). The majority of patients
with rosacea showed serum reactivity to the 62-kDa protein
(85Æ7%, 18 ⁄21), nine patients (42%) showed reactivity to the
83-kDa protein and six patients (28Æ5%) demonstrated reactiv-
ity to both proteins simultaneously. Of controls who showed
reactivity to the Bacillus antigens, 89% (8 ⁄9) reacted to the 62-
kDa antigen, 22% showed serum reactivity to the 83-kDa anti-
gen and 11% (1 ⁄9) showed reactivity to both antigens simul-
taneously.
Characterization of the 62- and 83-kDa proteins by liquid
chromatography-mass spectrometry analysis
In the current work the two proteins that patient sera reacted
with (i.e. the 62- and 83-kDa proteins) were excised and pro-
cessed for identification by LC-MS analysis as described
(Fig. 2). The results identified the 62-kDa protein as showing
homology to a heat shock protein, groEL chaperonin
(Table 1). This protein is highly immunogenic and provokes a
strong immune response in mice18 and humans.19 Bacterial
heat shock proteins are known to have antigenic properties,
and proteins homologous to groEL have been identified in
Escherichia coli, Mycobacterium tuberculosis, Pseudomonas aeruginosa and
Burkholderia pseudomallei.20,21 The 83-kDa protein was identified
as showing homology to aconitate hydratase (Table 1). This
protein is increased in expression during periods of oxidative
stress in bacteria and is highly immunogenic.22 These results
62 kDa 
83 kDa 
kDa
175
80
58
46
30
25
17
7
Case No. 15 14 10 8
(a) (b) (c) (d)
Fig 1. Western blot analyses of patient and control sera.
Representative examples: (a) positive serum immunoreactivity to both
83- and 62-kDa protein bands (marked by arrows, case no. 15); (b)
positive to the 62-kDa protein band (case no. 14); (c) positive to the
83-kDa protein band (case no. 10); (d) negative to both protein
bands (case no. 8).
62 kDa
83 kDa
(a) (b)kDa
175
80
58
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7
Fig 2. (a) Bacillus oleronius proteins separated by sodium
dodecylsulphate polyacrylamide gel electrophoresis. (b) Western blot
analyses of patient sera highlighting the 83- and 62-kDa
immunoreactive protein bands.
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indicate that the two proteins to which sera from patients
with rosacea react are highly immunogenic and may play a
role in triggering an immune response and thus inducing in-
flammation and tissue degradation.
Discussion
Rosacea is a complex disease that may involve environmental,
genetic, immunological and microbiological components.2–5
The significance of the elevated Demodex density on the faces of
patients with rosacea has been the subject of much speculation,
and its role in the induction of the disease is not defined.10–12
There is increasing evidence to suggest a potential role for bac-
teria in the induction and persistence of this condition. Antibi-
otics used to treat rosacea suggest a potential role for bacteria in
the induction of this condition, although such antibiotics may
also display anti-inflammatory properties.3 Staphylococcus epidermi-
dis samples isolated from patients with rosacea (but not con-
trols) were consistently beta-haemolytic and grew better at
37 C than at 30 C, suggesting a link between mesophilic
hydrolytic bacteria and rosacea.23 In addition this bacterium has
been isolated from the pustules of patients with PPR and from
the eyelids of patients with ocular rosacea, indicating a potential
role in the induction of these conditions.24 Previous work has
indicated a positive correlation between the reactivity of serum
from patients with rosacea to B. oleronius proteins and the occur-
rence of PPR14 and ocular rosacea,15 thus suggesting a possible
role for this bacterium in the induction of these conditions. The
two proteins that patient sera react with were identified as groEL
chaperonin and aconitate hydratase. Both of these are highly
immunogenic,18,19,22 and their release from bacteria within
Demodex mites within the pilosebaceous unit could lead to the
initiation of an immune reaction and inflammation in that
vicinity. This bacterium has also been recorded in Demodex mites
from patients with chronic blepharitis, and it was suggested that
the Bacillus played a role in the development of some forms of
this condition.25
It has been demonstrated previously that antigens released
from B. oleronius are capable of activating neutrophils and so
could play a role in provoking inflammation around the pilo-
sebaceous unit.16 B. oleronius may be an endosymbiont of Demo-
dex mites and may facilitate the digestion of food as they do in
the termite.26 The release of antigens from this bacterium and
other bacteria from dead Demodex mites in the pilosebaceous
unit may cause the activation of neutrophils in the vicinity of
the unit and thus explain why in some cases of rosacea the in-
flammation is centred on the pilosebaceous unit.
We have previously demonstrated that 29% of controls
show serum reactivity to the Bacillus antigens.14 In the current
study 40% of controls demonstrated serum reactivity to the
62- and 83-kDa proteins of B. oleronius. We speculate that B. ol-
eronius is a normal part of the flora of Demodex mites, but that
the low numbers of mites in controls may indicate a low den-
sity of bacteria and bacterial proteins released upon the death
of mites, which may not be sufficient to provoke a significant
immune response. The elevated density of mites in patients
with rosacea,18 and consequently their attendant bacteria, may
result in the release of large amounts of stimulatory Bacillus
proteins that leak from the pilosebaceous unit and provoke an
immune response.16
Erythematotelangiectatic rosacea is characterized by ery-
thema, oedema and telangiectasia.2,5,6 Antibiotic therapy may
be used to control the condition,3 suggesting a possible role
for bacteria in its aetiology. We postulate that these antibiotics
kill the Bacillus within the Demodex mites, and thus no new
stimulatory proteins are released. The loss of the endosymbi-
otic bacteria would adversely affect the metabolism of the
Demodex mites and their numbers would decline. A resurgence
in the Demodex population could occur after the cessation of
antibiotic therapy, thus leading once again to an increase in
the population of B. oleronius in the face, and the reactivation
of symptoms. The identification of a role for bacteria in rosa-
cea may facilitate the development of more effective therapies
that target the bacterial population within Demodex mites.
What’s already known about this topic?
• Patients with rosacea demonstrate a high density of Dem-
odex mites in the skin, but the role of these or associated
microbes in the induction of the condition is unclear.
What does this study add?
• Patients with erythematotelangiectatic (type 1) rosacea
demonstrate a strong serum reactivity to proteins from
Bacillus oleronius, which was originally isolated from a
Demodex mite from a patient with rosacea.
• This result suggests that immune reactivity to the Bacillus
proteins may have a role in the induction of this form
of rosacea.
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